Results
A total of 31 patients received 70 sessions of B-TACE using a 1.8-Fr tip micro balloon catheter Occlusafe®.
| Sub-sub segmental | 11 |
| Sub segmental | 35 |
| Segmental | 14 |
| Lobar | 5 |
| Right inferior phrenic artery | 5 |
Technical Success
The overall technical success rate was 99% (69 out of 70 sessions).
As procedural complications, rupture of the micro balloon (n = 3) and aneurysmal dilatation at the site of balloon occlusion (n = 2) were encountered.
Blood parameters
There were no significant differences in any parameters between blood biochemical examination before and between two to four weeks after the procedure.
Conclusion
A 1.8-Fr tip micro balloon catheter Occlusafe® enables selective catheterization in patients with HCC and B-TACE using the 1.8-Fr tip micro balloon catheter is a safe procedure
